A probe provides a simple, yet powerful visual tool for highly sensitive detection of demethylase activity. Through the use of m 6 A-probe, we were able to achieve real-time imaging and single-cell flow cytometry analyses of FTO activity in HepG2 cells. We also successfully applied the probe to monitor dynamic changes in FTO activity and m
A) is an important post-transcriptional modication that is present in more than half of all mammalian messenger RNAs (mRNAs).
1-3 It is currently of intense chemical and biological interest because of its critical roles in various key cellular processes, such as the regulation of mRNA stability, translation efficiency and alternative splicing. [4] [5] [6] [7] [8] [9] [10] In recent years, it has become increasingly clear that the m 6 A methylation level in mRNA is dynamically regulated by a complex interplay between the m 6 A methyltransferases (MTases), such as the METTL3-METTL14-WTAP complex, [11] [12] [13] which catalyse the installation of m 6 A modication on mRNA and the m 6 A demethylases, such as FTO (fat mass and obesity-associated protein) 14 and ALKBH5 (AlkB homologue 5), 15 which directly remove the m 6 A mark via an oxidative-demethylation mechanism. Both FTO and ALKBH5 belong to the broader family of iron-and 2-oxoglutarate (2OG)-dependent AlkB dioxygenases which also includes Escherichia coli AlkB and eight human homologues, ALKBH1-8. [16] [17] [18] There is emerging evidence that the aberrant expression of these m 6 A demethylases may underlie the pathogenesis of a number of human diseases. FTO, in particular, is strongly associated with a range of metabolic and neurodegenerative disorders, including obesity, 19 diabetes, 20 non-alcoholic steatohepatitis (NASH) 21 and Alzheimer's diseases, 22 whilst ALKBH5 is likely involved in spermatogenetic defect and male infertility. 15, 23 Despite the strong physiological links, the exact molecular mechanisms for the m 6 A demethylases remain unclear. Hence there is currently tremendous interest in developing analytical tools to facilitate the functional and mechanistic studies of these enzymes, with a longer term view of validating their therapeutic potentials.
However, the m 6 A demethylase activity of FTO and ALKBH5
has proven challenging to assay, especially in cells, in part due to the small size and chemical inertness of the N 6 -methyl group they remove. Consequently, at present, only few methods have been reported for their analysis. This includes the detection of demethylated DNA/RNA product using HPLC or MALDI-TOF mass spectrometry, 14,15,24-26 gel electrophoresis of enzyme-digested substrates, 26 uorescence analysis of uorescein-labelled ssDNA substrate, 26 immuno-detection with m 6 Aspecic antibodies 14, 15, [24] [25] [26] and, more recently, RNA aptamerbased and MazF endonuclease-based uorescence assays. 27, 28 Whilst these methods are useful, many of them are limited by poor sensitivity, low throughput and incompatibility with livecell applications. Moreover, to date, no method exists which permits the real-time analysis of m 6 A-demethylase activities in living cells; this severely hinders the study of these clinicallyimportant enzymes. We, 29 and others, [30] [31] [32] [33] have previously showed that although m 6 A is able to participate in Watson-Crick base pairing in DNA/ RNA duplexes, this is achieved by restricting the N 6 -methylamino group in an energetically unfavourable anti-conformation (with respect to N 1 in the purine ring). Thus the presence of m 6 A modication has a general destabilising effect on DNA/ RNA duplexes and could, in fact, trigger a major overall conformational change in certain sequence contexts. Indeed, m 6 A has been shown to induce a dramatic duplex-hairpin conversion in some RNA sequences.
29,31
The structuremodifying inuence of m 6 A has also been observed in cellular
RNAs, such as human MALAT1 (metastasis associated lung adenocarcinoma transcript 1), where m 6 A apparently modulates RNA-protein interactions by altering the local RNA structure. 34, 35 Inspired by these fascinating observations, we envisaged that m 6 A-induced conformational change could provide a basis for sensing m 6 A (de)methylation in cells.
Herein, we describe the rst example of a uorescent m 6 Aswitchable probe, which enables the highly sensitive and selective detection of FTO demethylase activity both in vitro and in living cells. The analytical principle is illustrated in Fig. 1a . The m 6 A-probe is a structurally dynamic oligonucleotide probe which, by design, has the capacity to switch between different conformations according to its m 6 A methylation status. When the probe is methylated, it preferentially adopts a B-like hairpin structure. Removal of the m 6 A methyl group by FTO, however, triggers a rapid and spontaneous transformation to an Aduplex. To visualise this conformational change, we employed the pyrene-labelled uridine 2 0 -O-(1-pyrenylmethyl)uridine (U P ; Fig. 1b) as the uorescent reporter. U P is particularly suited for our probe design because its uorescence emission is highly sensitive to its local structural environment. Previous A-probe by FTO. The N 6 -methyl group is first oxidised to a hydroxymethyl group, which then fragments spontaneously to give formaldehyde and the demethylated base. ALKBH5 could not demethylate the m photophysical studies showed that U P is quenched when stacked with other nucleobases in a single-stranded or hairpin loop environment due to photo-induced charge transfer from the pyrene to neighbouring nucleobases. [36] [37] [38] [39] However it emits brightly when in a compact A-duplex environment due to disposition of pyrene to the non-quenching minor groove.
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Although U P and other pyrene-modied nucleotides have been widely used to probe DNA/RNA structures, base-ipping and protein-nucleic acid interactions, [36] [37] [38] [39] to date, U P has not been applied to the study of m 6 A methylation dynamics. There is also no report of pyrene-based probe that switches uorescence in response to methylation status. As we shall demonstrate, the uorescent m 6 A-probe provides a simple, yet powerful visual tool that permits the highly sensitive detection of FTO demethylase activity. Through the use of m 6 A-probe, we were able to achieve real-time imaging and single-cell ow cytometry analysis of FTO activity in living cells. We also successfully applied the probe to monitor dynamic changes in FTO activity and m 6 A methylation levels during 3T3-L1 pre-adipocyte differentiation. The strategy outlined here is simple, inexpensive and amenable to highthroughput format. It is also highly versatile and may, in principle, be applied to the study of a range of RNA demethylases and, more widely, other RNA modifying enzymes. Prior to this study, there is no report of assay method that enables the direct monitoring of FTO m 6 A-demethylase activity in living cells. We are also not aware of any cell-based assay that specically target FTO over ALKBH5 (the only other human enzyme currently known to demethylate m 6 A in RNAs). Hopefully the development of this highly selective approach will advance our understanding of the roles of FTO in m 6 A-mediated epigenetic processes and its mechanistic connection to human diseases. segment' (underlined), anked on both side by two 'CG segments'. Because of their self-complementary nature, they can inherently form two main conformations in solution, namely (1) duplex structure, by engaging in intermolecular base pairing, and (2) hairpin structure, by folding back on themselves. 40 We hypothesised that, in certain sequence contexts, the introduction of an m 6 A modication in the 'middle segment' could signicantly disrupt duplex base-pairing, thereby forcing the probe to adopt a hairpin conformation (where m 6 A could be stably localised within the hairpin loop). Removal of the m 6 A modication, however, is expected to restore full base pairing ability and thus favours the alternative duplex structure.
Results and discussion
The m 6 A-probe switches between hairpin and duplex conformations according to its methylation status
To test our hypothesis, we rst compared the UV-melting prole of each of the methylated probes (1a-12a) with that of their nonmethylated counterparts (1b-12b) to obtain a qualitative picture of the inuence of m 6 A methylation on their secondary structures ( Fig. 2 and S1-S6 †). The assignment of hairpin and duplex conformations was initially made based on the hyperchromicity of the melting curves and the dependence of melting temperatures (T m s) on strand concentration; melting transitions that exhibit low UV hyperchromicity ($10%) and concentrationindependent T m s are suggestive of a monomolecular hairpin structure, whereas those that show strong hyperchromicity ($20%) and concentration-dependent T m s are characteristic of a bimolecular duplex structure. The results are summarised in Table 1 . Amongst the sequences investigated, probes 8, 11 and 12 were found to be structurally-responsive towards m 6 A methylation status. Consistent with our design strategy, they preferentially adopt a hairpin structure when methylated, but convert to a duplex structure upon removal of the m 6 A modi-cation. The transformation of the probe from hairpin to duplex structure appears to be primarily an enthalpy-driven process, as evidenced by the highly favourable enthalpy change (e.g. DDH (12a / 12b) ¼ À56.9 kcal mol À1 ) which counteracts the large ), [29] [30] [31] [32] [33] suggesting that m 6 A is generally wellaccommodated within 2 0 -O-methyl RNA duplexes.
To conrm the observed conformational change, we performed circular dichroism (CD) analysis of probes 8, 11 and 12, which clearly revealed a B-like hairpin structure for the methylated probes and an A-form duplex for the corresponding non-methylated equivalents ( Fig. 2c and S8 †). Native polyacrylamide gel electrophoresis further revealed only one discrete band for each strand, indicating that they exist exclusively as hairpin or duplex structure, rather than a mixture of conformations ( Fig. 2d and S8d †). Thus these probes likely undergo complete hairpin-duplex conversion in response to methylation changes. We appreciate that for more vigorous proof of secondary structure, other analytical methods such as 2D NMR studies are required. Nevertheless, data from the present study clearly demonstrated that probes 8, 11 and 12 have the capacity to spontaneously adopt two distinct conformations according to their methylation status, thus they could potentially function as m 6 A-switchable probes for sensing m 6 A demethylase activity.
Direct visualisation of methylation changes using pyrenelabelled uridine as the uorescent reporter
We next investigated whether it is possible to monitor the conformational dynamics of the probe using 2 0 -O-(1-pyrenylmethyl)uridine (U P ) as the uorescent sensor (Fig. 1b) . To identify suitable positions for uorophore placement, each uridine residue in probes 8, 11 and 12 was systematically replaced with a U P residue. Fluorescence analysis (l ex 340 nm)
of the resulting probes 13-17 ( Table S2 †) indicates that U P emission is most effectively quenched (via PET) when incorporated at the U 7 or U 9 positions of probe 12 (Fig. 3, S9 and S10 †).
This gives starting methylated probes with very low uorescence quantum yields (F F ) of 0.04 (16a) and 0.06 (17a), respectively. Their non-methylated counterparts, 16b and 17b, however, are brightly uorescent (F F 0.24 and 0.25) and exhibit at least 4-fold greater uorescence intensity. Due to the modular nature of our probe design, it is possible to further amplify the uorescence signal of the probe through judicious placement of several U P monomers, as exemplied by 18a where the concurrent incorporation of two U P residues led to a dramatic increase in uorescence light-up response (DF F $ 12-fold; 3 340 ¼ 9.4 Â 10 4 M À1 cm À1 ), with concomitant appearance of a broad excimer emission peak at $475 nm (Fig. 3b) . We appreciate that the presence of bulky U P residue might alter the hairpin conformation of 18a, nevertheless, our results from UVmelting, CD and native PAGE analyses revealed little or no change in its overall secondary structure compared with parent probe 12a ( Fig. 2 and S7 †). The non-methylated equivalent 18b also retained the ability to dimerise into stable A-duplex structure (DG 310 ¼ À15:7 kcal mol À1 ; Table 1 ).
Taken together, these results demonstrated that it is possible to visualise methylation changes in the probe using U P as the uorescent reporter. Because 18a gave the greatest uorescence switch-on response and signal-to-noise ratio, it was selected as our representative m 6 A-probe for further investigation.
The m 6 A-probe enables highly sensitive detection of FTO demethylase activity
We rst examined whether the m 6 A-probe could serve as uo-rogenic substrate for FTO. In our in vitro m 6 A-probe assay, 10 mM of the probe was incubated with FTO (0.5 mM) in the presence of Fe(II) (cofactor; 100 mM), 2-oxoglutarate (2OG; cosubstrate; 100 mM) and L-ascorbate (2 mM) under physiologicallyrelevant conditions (50 mM HEPES buffer, pH 7.4, 37 C). The uorescence of the reaction (l ex 340 nm) was monitored over time and the emergence of uorescent demethylated probe 18b was indicated by an increase in emission at 410 nm. As shown in Fig. 4a , strong uorescence could be detected within 30 min of incubation, suggesting that the probe was readily demethylated by FTO. Maximum signal was reached in approximately 2 h, giving a $10-fold increase in uorescence intensity. Such a large uorescence light-up response is remarkable considering only a single methyl group change between the probe and the demethylated product. Thus the use of m 6 A-probe enables highly sensitive detection of FTO demethylase activity. Consistent with uorescence analysis, HPLC analysis of the reaction mixture at various time points showed a timedependent increase in formation of demethylated product with concomitant decrease in m 6 A-probe level ( Fig. 4c-f) .
Moreover, the product concentration correlates linearly with the uorescence intensity (Fig. 4j) , hence the uorescence signal provides a direct indication of FTO demethylase activity.
To conrm that the observed uorescence increase was specically triggered by FTO demethylase activity and not due to auto-uorescence or other non-specic mechanisms, we repeated the m 6 A-probe assay using an FTO missense mutant, FTO
R316Q
, which has signicantly reduced (80% less) demethylase activity.
14 As anticipated, FTO R316Q gave a greatly diminished uorescence response compared with wild-type FTO, clearly demonstrating that uorescence activation was indeed induced by FTO-dependent demethylase activity ( Fig. 4a and g ). Consistent with this nding, control experiments lacking FTO or any of the key assay components i.e. 2OG (cosubstrate) or Fe(II) (cofactor) did not result in any uorescence increase (Fig. S12 †) . Subsequent kinetic analysis using a HPLC-based assay revealed that the m 6 A-probe is a reasonably good substrate for FTO (k cat / K m ¼ 1.05 min À1 mM
À1
; Fig. 4k and S11 †), and could, in fact, be demethylated with similar efficiency as ssRNA and ssDNA substrates containing the GG(m 6 A)CU consensus motif. This result is interesting because it suggests that, in addition to DNA and RNA substrates, FTO is also able to demethylate m To further explore whether the hairpin-duplex structural change is truly essential for probe uorescence activation, we prepared control probe 19a-an analogue of m 6 A-probe wherein the adenine base at position 6 was replaced with cytosine ( Fig. 1d) . This single base substitution renders the control probe non-palindromic, thus unable to undergo hairpin-duplex conversion on demethylation, as veried by UV-melting analysis (Table 1 and Fig. S7 †) . Treatment of the control probe with FTO The fluorescence emission spectra (l ex 340 nm) of the probes were recorded at 5 mM strand concentration under physiologically-relevant conditions (10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4, 37 C). Two pyrene emission peaks at l em $385 nm and $410 nm were observed. The concurrent placement of two U P residues at U 7 and U 9 positions i.e. 18a (m 6 A-probe) led to a dramatic $12-fold enhancement in fluorescence light-up response, with concomitant appearance of a broad excimer emission peak at $475 nm. The fluorescence quantum yields were determined with AE10% accuracy. For the effects of U p substitution on probes 8 and 11, see failed to produce any uorescence increase (Fig. 4a) despite clear evidence of demethylated product formation by HPLC analysis (Fig. 4h) . Thus, uorescence turn-on is strictly dependent on a switch in probe conformation from hairpin to duplex structure.
The m 6 A-probe is remarkably selective for FTO over ALKBH5 and other subfamily members
We next evaluated the specicity of the m 6 A-probe by testing it against several FTO subfamily members, namely ALKBH2,
41-43

ALKBH3
43,44 and ALKBH5. 15, 45 These enzymes are of particular interest because they not only share high levels of sequence and structural homology with FTO, but also possess direct nucleic acid demethylase activities. 25 The results from HPLC-based and uorescence assays showed negligible demethylated product formation and uorescence activation for all enzymes investigated, suggesting that the m 6 A-probe is highly selective for FTO over its subfamily members (Fig. S12 †) . The apparent lack of uorescence response towards ALKBH5 is notable because ALKBH5 is also known to demethylate m 6 A on mRNAs ( Fig. 4a and l). Such exceptional selectively renders the probe potentially useful for studying the respective roles of FTO and ALKBH5 in m 6 A-mediated epigenetic processes. The mechanism by which the m 6 A-probe discriminates against ALKBH5 is unclear at present, however, in light that ALKBH5 could effectively demethylate the RNA equivalent of the m 6 A-probe, selectivity is likely attributed to the 2 0 -O-methyl backbone.
Besides selectivity, the m 6 A-probe also exhibits excellent sensitivity and dynamic range. Titration of the probe (10 mM) with decreasing concentrations of FTO indicated that m 6 A demethylase activity could be detected at FTO concentration as low as 10 nM (Fig. S13 †) . This is at least a 100-fold more sensitive than conventional assay performed under similar conditions, where micromolar enzyme concentrations are typically required.
The m 6 A-probe is not methylated by m 6 A MTases and is highly stable in cell lysate
One potential concern with the use of m 6 A-probe in cells is that the demethylated probe could, in principle, be re-methylated back to the hairpin structure by cellular m 6 A methyltransferases (MTases), leading to a reversal of uorescence activation. To investigate this possibility, we assayed the demethylated probe against METTL3 and METTL14, [11] [12] [13] which are the only two m 6 A MTases identied to date. We also tested it against m 5 C RNA MTases, NSUN2 47, 48 and DNMT2, 49 to examine for possible methylation on the 'CG segment' of the probe. Interestingly, in all cases, there was no methylation of the demethylated probe, even aer prolonged incubation (8 h), as determined by MALDI-TOF MS analysis (Fig. S14 †) ; there was also no appreciable change in the uorescence intensity of the probe (Fig. 4b) . In sharp contrast, control experiment using the methylating agent methylmethane sulfonate (MMS) resulted in a rapid decline in uorescence signal, suggesting that probe uorescence could indeed be reversed by methylation (Fig. 4b) . Recent studies suggested that many of the MTases exhibit strict sequence and/or structural requirements for substrate recognition. The m 6 A MTases for instance specically recognise and bind to the GG(m 6 A)CU consensus motif. [11] [12] [13] This may explain, at least in part, the apparent lack of methylation of the demethylated probes by these enzymes.
To investigate the potential loss of probe uorescence due to other nucleic acid modifying enzymes or cellular nucleases, we further performed time-course uorescence analysis of the m 6 Aprobe in HepG2 cell lysate, where FTO is abundantly expressed.
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As shown in Fig. S15 , † the demethylated probe product formed rapidly in cell lysate where it remained strongly emissive for at least 24 h with no obvious decline in uorescence. This suggests that the probe has good photostability and is fairly resistant to nuclease degradation. Our combined results, therefore, established m 6 A-probe as a highly sensitive and selective probe suitable for visualising FTO demethylase activity in cells.
The m 6 A-probe assay enables high-throughput screening of
FTO inhibitors
On the basis of these promising data, we next investigated whether the developed m 6 A-probe assay could be applied to the high-throughput screening of FTO inhibitor. To assess the performance of our assay, a set of structurally-diverse small molecules (Fig. 5a) ) and non-inhibitor A-probe assay. Percent enzyme activity was calculated by normalising to the fluorescence signal without inhibitor (100%) and without m 6 A-probe (0%). Data are expressed as mean AE SD of three replicates. (c) The Z 0 factor for the m 6 A-probe assay was determined in a 384-well format, using the method described by Zhang et al. 51 A total of 40 independent assays were run with either LipotF (positive control) or DMSO (negative control).
isonicotinic acid 40 were individually incubated at various concentrations with FTO (50 nM) and m 6 A-probe (10 mM) in a 384-well plate, and their uorescence spectra simultaneously recorded on a uorescence microplate reader. The inhibition curves are shown in Fig. 5b . With the exception of isonicotinic acid, all compounds investigated induced a clear dose-dependent decrease in uorescence intensity. The determined IC 50 s are also comparable with previously reported values (Fig. 5a ), thus the m 6 A-probe assay is able to successfully identify FTO inhibitors across diverse chemical scaffolds. To further evaluate the quality and reproducibility of our m 6 A-probe assay for screening in a 384-well format, we determined the Z 0 factor using the method described by Zhang et al. 51 (for experimental details, see ESI †). The average Z 0 factor for our assay was found to be 0.68, which indicates excellent statistical reliability (Fig. 5c ). Taken together, the results validate our m 6 A-probe assay as a robust method for high-throughput screening of FTO inhibitors.
The m 6 A-probe enables real-time monitoring of FTO activity in living cells
We next proceeded to explore the utility of the m 6 A-probe for imaging FTO activity in live-cells. To this end, 10 mM of the m 6 Aprobe or control probe 19a was delivered into HepG2 cells via streptolysin-O (SLO) reversible permeabilisation method 52 and then analysed using uorescence microscopy; it has been suggested that this method is more rapid and efficient compared with conventional transfection methods.
52 Preliminary experiments in our lab further showed that SLO-permeabilisation is an effective method for m 6 A-probe delivery and that SLO treatment does not signicantly affect FTO expression in HepG2 cells (Fig. S16 †) . As shown in Fig. 6a and b, bright blue uo-rescence could be observed within the cells aer 1 h incubation. This represents a 7-fold increase in uorescence relative to the control probe (Fig. 6c) , which is fairly substantial considering suboptimal lter settings (l ex 340-380 nm; l em 435-485 nm). Notably, the uorescence appears to accumulate in the cytoplasm, with little or no detectable signal in the nucleus (Fig. S17 †) . In light of emerging evidence suggesting that FTO shutters between the nucleus and the cytoplasm where it likely serves different cellular functions, [53] [54] [55] the selective distribution of m 6 A-probe in the cytoplasm may allow us to specically study FTO activity on cytoplasmic mRNAs. Despite toxicity concerns associated with the use of pyrene-based uorophore in general, MTT cytotoxicity assays showed that the m 6 A-probe is reasonably well-tolerated by HepG2 and 3T3-L1 cells, with >80% of the cells remaining viable aer treatment with 50 mM probe for 24 h (Fig. S18 †) . The probe also did not signicantly affect FTO expression in cells (Fig. S16 †) . In addition to live-cell imaging, we further demonstrated that the m 6 A-probe is compatible with ow cytometry analysis (l ex 355 nm; l em 379 nm) and could provide real-time monitoring of FTO inhibition in cells. As shown in the time-course ow cytometry proles (Fig. 6d-f) , incubation of HepG2 cells with various concentrations of ethyl LipotF (a cell-permeable FTO inhibitor developed in our lab; PubChem ID: 126970770) 25 for 1 hour prior to the addition of m 6 A-probe led to a dose-dependent reduction in uorescence signal. The control probe 19a, however, did not produce any uorescence change, as anticipated.
Flow cytometry experiment further demonstrated that the m 6 A-probe is highly sensitive towards changes in cellular FTO expression levels. In particular, stable overexpression of FTO in HepG2 cells caused a profound increase in probe uorescence, whilst FTO knockdown via transient transfection with FTOspecic siRNA led to a signicant reduction in emission (Fig. 6g, h and S19 †). The uorescence intensity was unchanged with ALKBH5 overexpression or knockdown, thus, consistent with our in vitro data, the m 6 A-probe is exclusively activated by FTO and not by ALKBH5. The m 6 A-probe therefore provides a single assay platform that permits applications both in vitro and in living cells.
The m 6
A-probe provides a powerful tool for following dynamic changes in endogenous FTO level during cellular differentiation It is increasingly clear that both FTO expression level and m 6 A methylation pattern are dynamically regulated during cellular differentiation 7, 56 and pathological processes, such as tumourigenesis, 57 DNA damage, 58 heat shock 59 and stress responses.
60 Recent study by Zhao et al. in particular showed that FTO expression levels decreased during 3T3-L1 preadipocyte FTO FTO expression levels decreased during 3T3-L1 pre-adipocyte differentiation and this correlated inversely with global m 6 A levels. 7 We were therefore interested in exploring whether the m 6 A-probe is able to report dynamic changes in endogenous FTO activity during cellular differentiation. To this end, 3T3-L1 pre-adipocytes were treated with the probe at different time points of adipogenesis i.e. Day 0 (prior to treatment with mitotic inducing agent), 3, 6, and 9 and then analysed by uorescence microscopy and ow cytometry. Consistent with the above-mentioned report, 7 cells on Day 3, 6, and 9 of differentiation exhibited a 1.4-, 2.0-and 5.4-fold decrease in uorescence intensity, respectively, relative to Day 0 ( Fig. 7a and b) , suggesting a time-dependent reduction in FTO level and/or activity during adipogenesis. Remarkably, the observed uorescence decrease also corresponds to a 1.3-, 1.6-, and 2.1-fold increase in m 6 A levels in mRNAs, respectively, as determined by dot-blot analysis ( Fig. 7c and d) . Thus the uo-rescence intensity provides a direct read-out of cellular FTO activity. Taken together, the results showed that our m 6 A-probe can provide a simple, yet highly sensitive tool for following dynamic changes in cellular FTO activity. (Fig. 1d) . Remarkably, the removal of these modied bases triggered a similar hairpinduplex conformational change, as demonstrated by CD analysis (Fig. S20 †) . The observed conformational change was again accompanied with signicant uorescence light-up responses (DF F > 9; Fig. S20d †) . Thus our m 6 A-probe strategy is highly versatile and could potentially be adapted to the study of a range of nucleic acid-modifying enzymes.
Conclusions
Overall, we have provided proof of principle that a novel strategy employing uorescent m 6 A-switchable probe could enable highly sensitive detection of FTO m 6 A-demethylase activity both in vitro and in living cells. The developed m 6 A-probe assay is simple, inexpensive and permits the direct analysis of FTO activity without recourse to radioactive substrates or cumbersome techniques. This assay also requires only small amount of protein (low nanomolar concentrations), thus avoiding the drawbacks of high protein consumption and limited dynamic range associated with current assay methods. Through the use of the m 6 A-probe, the removal of a single methyl group is dramatically amplied ($10-fold). This enables highly sensitive detection of FTO demethylase activity.
Importantly, the m 6 A-probe provides a powerful visual tool for direct imaging and single-cell ow cytometry analysis of FTO activity. In this study, we have successfully applied the probe to the real-time monitoring of FTO inhibition in HepG2 cells. We also demonstrated that the m 6 A-probe is highly sensitive towards cellular FTO expression levels and could report on subtle changes in FTO activity during 3T3-L1 pre-adipocyte differentiation. Thus the m 6 A-probe may provide insights into the dynamic regulation of cellular processes by FTO. We further showed that the m 6 A-probe strategy can be applied to the screening of FTO inhibitors across diverse chemical scaffolds.
Given the very high level of current interest in FTO as an m 6 A 'eraser' and as disease target, the development of a single assay platform that allows both the functional study of FTO and the high-throughput discovery of FTO therapeutic leads shall be of signicant biological and medical interest.
One limitation of this approach is that, as oppose to genetically-encoded sensors, it is necessary to deliver the m 6 Aprobe into cells exogenously, and this introduces additional handling steps. The probe delivery efficiency also likely varies between different cell types. Moreover, this method is not suitable for base modications that do not signicantly impact duplex stability, such as 5-methylcytosine (m dC also undergo spontaneous hairpinduplex transformation, with concomitant uorescence activation. Hence the developed assay could, in principle, be adapted to the study of a range of nucleic acid-modifying enzymes.
Prior to this study, there is no report of assay method that enables the direct analysis of FTO m 6 A-demethylase activity in living cells. We are also not aware of any cell-based assay that selectively target FTO over ALKBH5 (the only other human enzyme currently known to demethylate m 6 A in RNAs). The development of this highly selective approach may prove valuable in dissecting the respective roles of FTO and ALKBH5 in m 6 A-mediated epigenetic processes, which hopefully will advance our understanding of mechanistic links between FTO and human diseases.
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